one would think it is good news Oscar. However I have learnt that nothing would surprise.
Perhaps the restructure could be - MK returns to exec director duties, Albert Tham becomes non exec external affairs and Royce director administration management.
As I have eluded to well before Royce appointment, I have the impression that the T20 have simply sat back and let this all evolve and we are now seeing the self destruction of extremely poor management. I hope so anyway.
If the restructure is driven by the current BOD as a last ditch effort to redeem we are doomed IMHO. The upside of any change is that you are unlikely to have any new BOD members take on a role such as RNI, without the support of RNI and their willingness to support the venture going fwd. You would have to question Royce taking on his role with the current BOD.
We could also be total off track too! Imagine getting a capable BOD and then being told the business is a debacle and unfixable and best for SH's not to throw good money after bad? Just throwing it out there! Nothing would surprise me.
- Forums
- ASX - By Stock
- AUR
- Ann: Trading Halt
Ann: Trading Halt, page-28
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AUR (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.336M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1216025 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 250000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1216025 | 0.006 |
4 | 965236 | 0.005 |
4 | 1110000 | 0.004 |
3 | 2440000 | 0.003 |
3 | 2200000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 250000 | 1 |
0.008 | 393286 | 2 |
0.009 | 645731 | 2 |
0.010 | 984315 | 2 |
0.012 | 32225 | 1 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
AUR (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online